Therefore, to simulate the metabolic effect of targeting OXCT1, we exploited the chiral property of βHB by treating the cells with the metabolically inactive enantiomer S-βHB (5 mM) at a dose range of natural ketosis without causing severe ketoacidosis (30, 31). This evidence concerns the gene OXCT1 and type 2 diabetes mellitus.